Saatja: Webdesktop <
[email protected]>
Saadetud: 21.04.2022 16:30
Adressaat: SM Info <
[email protected]>; Elen Ohov <
[email protected]>
Koopia: <
[email protected]>
Teema: Webdesktop: Kiri nr 10.2-11/404 /Second meeting of Directors-
General of Member State health ministries on the revision of
pharmaceutical legislation (10.05.2022)
Tere!Edastan Komisjoni kirja.Reg. number: 10.2-11/404Reg. kuupäev:
21.04.2022Sisu: Liikmesriikide tervishoiuministeeriumide peadirektorite
2. kohtumine farmaatsiaalaste õigusaktide läbivaatamiseks toimub
10.05.2022Second meeting of Directors-General of Member State health
ministries on the revision of pharmaceutical legislation
(10.05.2022)Heade soovidegaTiiu
[email protected]är, EV
alaline esindus EL juures
Ref. Ares(2022)3133118 - 21/04/2022
EUROPEAN COMMISSION
DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY
The Director-General
Brussels
SANTE.DDG1.B.5/AR/am(2022)3244806
NOTE TO THE PERMANENT REPRESENTATIONS OF THE MEMBER STATES
TO THE EUROPEAN UNION
Dear Sir / Dear Madam,
Subject: Second meeting of Directors-General of Member State health
ministries on the revision of pharmaceutical legislation
Following our previous successful meeting we aim to continue the constructive dialogue
with Member States at the level of Directors-General (DGs) of national health ministries
on important issues affecting the revision of the EU pharmaceutical legislation. For this
reason I would like to invite the DGs of national health ministries to a video conference
meeting on Tuesday the 10th of May 2022 from 14:30 to 16:00 CET.
Our discussion on this occasion will cover the principles around the concept of ‘unmet
medical need’ and its role in the future EU pharmaceutical system. This concept is
central to the revision of the EU pharmaceutical legislation planned for the end of the
year and due to its political relevance it would particularly benefit from a discussion
taking into account the national perspective.
I kindly ask the Member State permanent representations to forward this invitation to the
intended recipients so that they may reserve the space in their calendars. Finally, I kindly
ask that participants confirm their attendance to SANTE-PHARMACEUTICALS-
[email protected] by Monday, 2 May 2022 in order to receive further updates and
connection details directly.
Yours sincerely,
(e-signed)
Sandra GALLINA
c.c.: Mr J-F. Ryan, Ms. M. Moya Diaz, Mr A. Rys, Ms. O. Solomon,
Mr S. Giraud, Ms R. Ardeleanu, Ms T. Palmisano
ElectronicallyCommission
signed on 20/04/2022 20:45 (UTC+02)
européenne/Europese in accordance
Commissie, with Article 11 of Commission
1049 Bruxelles/Brussel, Decision (EU)
BELGIQUE/BELGIË 2021/2121
- Tel. +32 22991111
E-mail :
[email protected]
Saatja:
[email protected] <
[email protected]>
Teema: Second meeting of Directors-General of Member State health ministries on the revision of pharmaceutical legislation - 10 May 2022
Our reference: Ares(2022)3133118
Dear colleagues,
Please find attached an invitation on the above mentioned subject on behalf of Ms. Sandra Gallina, Director General of DG SANTE.
We would be grateful to receive confirmation of participants to the meeting by 2 May 2022.
Kindly note that this is sent by e-mail only.
Kind regards,
Unit “Medicines: policy, authorisation and monitoring“
[logo-ce-horizontal-en-quadri-jpg24]
European Commission
DG Health and Food Safety
_____________
This message represents solely the views of its author and can not be regarded as the official position of the Commission. It is intended solely for the person to whom it is addressed and may contain confidential information. If you have received this message in error, please notify me as soon as possible.